Home > Clinical Trials
Check All Search

Saved trials

Terminated
NCT03989713
Quizartinib and High-dose Ara-C Plus Mitoxantrone in Relapsed/Refractory AML With FLT3-ITD
11 Enrollment(s)
1 Study location(s)
Interventional (Phase II)
AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
Recruiting
NCT05540587
Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis
240 Enrollment(s)
7 Study location(s)
Interventional (Phase II)
Mitral Valve Stenosis
Atrial Fibrillation
Stroke
Systemic Embolism
Recruiting
NCT04151680
Anticoagulation on Demand After Percutaneous Coronary Intervention in High Bleeding Risk Patients
100 Enrollment(s)
2 Study location(s)
Observational
Ischemic Heart Disease
Atrial Fibrillation
Recruiting
NCT04687761
Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old
84 Enrollment(s)
15 Study location(s)
Interventional (Phase I|Phase II)
Leukemia, Myeloid, Acute
De Novo
Age More 60yr
Terminated
NCT04516941
CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19
60 Enrollment(s)
5 Study location(s)
Interventional (Phase III)
SARS-CoV Infection
COVID-19
Active, not recruiting
NCT04730037
Clinical Trial to Investigate Safety and Efficacy of Edoxaban in Patients With CTEPH (KABUKI)
74 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
CTEPH
Terminated
NCT05091528
A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers
2 Enrollment(s)
1 Study location(s)
Interventional (Phase I|Phase II)
HER2-positive Breast Cancer
HER2-positive Gastric Cancer
HER2-positive Colorectal Cancer
HER2-expressing Non-small Cell Lung Cancer
Active, not recruiting
NCT03895502
Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study
605 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Venous Thrombosis
Neoplasms
Anticoagulant